Japan took steps Saturday to fast-track its approval of the anti-viral drug remdesivir for the treatment of new coronavirus patients, as the domestic death toll topped 500 including cases from a cruise ship.The government revised a Cabinet order so it can drastically simplify steps to authorize medicines for COVID-19, the illness caused by the virus, on condition such drugs have been approved in the United States, Britain, Canada, Germany and France.The move by the Japanese government came after the U.S. Food and Drug Administration said Friday it has authorized the emergency use of the dru…READ FULL ARTICLE
